TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to compare the tolerability and acceptability of a formulation containing Hypertonic saline 7% (HS) alone and a formulation containing HS and Hyaluronic acid 0.1% in a population of Cystic Fibrosis (CF) patients who already showed poor tolerance to HS.


Options:
A: Arm Label: group A; Type: EXPERIMENTAL; Interventions: Other: Inhalable Hypertonic saline 7% + Hyaluronan 0.1% | Arm Label: group B; Type: EXPERIMENTAL; Interventions: Other: Inhalable Hypertonic saline 7% | Intervention Type: OTHER; Name: Inhalable Hypertonic saline 7% + Hyaluronan 0.1%; Assigned to Arm(s): group A | Intervention Type: OTHER; Name: Inhalable Hypertonic saline 7%; Assigned to Arm(s): group B
B: Arm Label: 7% saline; Type: EXPERIMENTAL; Interventions: Drug: 7% saline | Arm Label: 0.12% saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.12% saline | Intervention Type: DRUG; Name: 0.12% saline; Assigned to Arm(s): 0.12% saline | Intervention Type: DRUG; Name: 7% saline; Assigned to Arm(s): 7% saline
C: Arm Label: Group A; Type: N/A; Interventions: Behavioral: Qualitative Interview | Arm Label: Group B; Type: N/A; Interventions: Behavioral: Qualitative Interview | Arm Label: Group C; Type: N/A; Interventions: Behavioral: Qualitative Interview | Arm Label: Group D; Type: N/A; Interventions: Behavioral: Qualitative Interview | Arm Label: Group E; Type: N/A; Interventions: Behavioral: Qualitative Interview | Intervention Type: BEHAVIORAL; Name: Qualitative Interview; Assigned to Arm(s): Group A, Group B, Group C, Group D, Group E
D: Arm Label: Hypertonic Saline; Type: EXPERIMENTAL; Interventions: Drug: 6% Hypertonic Saline (HS), 4mL | Arm Label: Isotonic Saline; Type: ACTIVE_COMPARATOR; Interventions: Drug: 0.9% Isotonic Saline (IS), 4mL | Intervention Type: DRUG; Name: 6% Hypertonic Saline (HS), 4mL; Assigned to Arm(s): Hypertonic Saline | Intervention Type: DRUG; Name: 0.9% Isotonic Saline (IS), 4mL; Assigned to Arm(s): Isotonic Saline

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to compare the tolerability and acceptability of a formulation containing Hypertonic saline 7% (HS) alone and a formulation containing HS and Hyaluronic acid 0.1% in a population of Cystic Fibrosis (CF) patients who already showed poor tolerance to HS.


Options:
A: Intervention Type: DRUG; Name: hypertonic saline; Assigned to Arm(s): N/A
B: Arm Label: USUAL CARE; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: INHALATION WITH PEP DEVICE; Type: ACTIVE_COMPARATOR; Interventions: Device: INHALATION WITH PEP DEVICE (Acapella Duet) | Intervention Type: DEVICE; Name: INHALATION WITH PEP DEVICE (Acapella Duet); Assigned to Arm(s): INHALATION WITH PEP DEVICE
C: Arm Label: sodium chloride 6%; Type: EXPERIMENTAL; Interventions: Drug: sodium chloride 6% | Arm Label: sodium chloride 0,9%; Type: PLACEBO_COMPARATOR; Interventions: Drug: sodium chloride 0,9% | Intervention Type: DRUG; Name: sodium chloride 6%; Assigned to Arm(s): sodium chloride 6% | Intervention Type: DRUG; Name: sodium chloride 0,9%; Assigned to Arm(s): sodium chloride 0,9%
D: Arm Label: group A; Type: EXPERIMENTAL; Interventions: Other: Inhalable Hypertonic saline 7% + Hyaluronan 0.1% | Arm Label: group B; Type: EXPERIMENTAL; Interventions: Other: Inhalable Hypertonic saline 7% | Intervention Type: OTHER; Name: Inhalable Hypertonic saline 7% + Hyaluronan 0.1%; Assigned to Arm(s): group A | Intervention Type: OTHER; Name: Inhalable Hypertonic saline 7%; Assigned to Arm(s): group B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure
Brief Summary: The purpose of this study is to determine the efficacy of the Heart Failure Exercise and Resistance Training (HEART) Camp behavioral exercise training intervention on long-term adherence to exercise at 18 months in patients with heart failure. The central hypothesis is that the HEART Camp intervention group (HC) will have significantly better adherence to exercise at 18 months.


Options:
A: Arm Label: Cardiac Rehabilitation Peer Mentorship; Type: EXPERIMENTAL; Interventions: Behavioral: Cardiac Rehabilitation Peer Mentorship | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cardiac Rehabilitation Peer Mentorship; Assigned to Arm(s): Cardiac Rehabilitation Peer Mentorship
B: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Education | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education; Assigned to Arm(s): Intervention
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Individual Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Feedback | Arm Label: Feedback Friend; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Feedback, Behavioral: Feedback Friend | Intervention Type: BEHAVIORAL; Name: Individual Feedback; Assigned to Arm(s): Feedback Friend, Individual Feedback | Intervention Type: BEHAVIORAL; Name: Feedback Friend; Assigned to Arm(s): Feedback Friend
D: Arm Label: Enhanced Usual Care (EUC) exercise group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care Group | Arm Label: HEART Camp (HC) Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: HEART Camp (HC) Intervention Group | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care Group; Assigned to Arm(s): Enhanced Usual Care (EUC) exercise group | Intervention Type: BEHAVIORAL; Name: HEART Camp (HC) Intervention Group; Assigned to Arm(s): HEART Camp (HC) Intervention group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Brief Summary: The primary objective of this study is to evaluate the effect of the addition of idelalisib to ofatumumab on progression-free survival (PFS) in participants with previously treated chronic lymphocytic leukemia (CLL).


Options:
A: Arm Label: Lenalidomide; Type: EXPERIMENTAL; Interventions: Drug: lenalidomide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: lenalidomide; Assigned to Arm(s): Lenalidomide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Phase I, NHL; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Arm Label: Phase I, CLL; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Arm Label: 400/400 mg - Phase II, iNHL; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Arm Label: 1600/800 mg - Phase II, iNHL; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Arm Label: 400/400 mg - Phase II, aNHL; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Arm Label: 1600/800 mg - Phase II, aNHL; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Arm Label: 1000/1000 mg - Phase II, CLL; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Arm Label: Retreated Participants; Type: EXPERIMENTAL; Interventions: Drug: Obinutuzumab | Intervention Type: DRUG; Name: Obinutuzumab; Assigned to Arm(s): 1000/1000 mg - Phase II, CLL, 1600/800 mg - Phase II, aNHL, 1600/800 mg - Phase II, iNHL, 400/400 mg - Phase II, aNHL, 400/400 mg - Phase II, iNHL, Phase I, CLL, Phase I, NHL, Retreated Participants
C: Arm Label: Obinutuzumab; Type: EXPERIMENTAL; Interventions: Drug: obinutuzumab (RO5072759) | Arm Label: Rituximab; Type: ACTIVE_COMPARATOR; Interventions: Drug: rituximab | Intervention Type: DRUG; Name: obinutuzumab (RO5072759); Assigned to Arm(s): Obinutuzumab | Intervention Type: DRUG; Name: rituximab; Assigned to Arm(s): Rituximab
D: Arm Label: Idelalisib+ofatumumab; Type: EXPERIMENTAL; Interventions: Drug: Idelalisib, Drug: Ofatumumab | Arm Label: Ofatumumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ofatumumab | Intervention Type: DRUG; Name: Idelalisib; Assigned to Arm(s): Idelalisib+ofatumumab | Intervention Type: DRUG; Name: Ofatumumab; Assigned to Arm(s): Idelalisib+ofatumumab, Ofatumumab

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of Blood Pressure and Endothelial Function Pregnancy After Acute and Daily Consumption Flavanol-rich Chocolate Among Healthy Pregnant Women: a Pilot Randomized Controlled Trial
Brief Summary: The purpose of this study is to to test the feasibility of design methods and procedures for later use on a larger scale and to examine the acute and chronic effect of consumption of flavanol-rich chocolate on endothelium function and blood pressure in healthy pregnant women.


Options:
A: Arm Label: Flavanol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cocoa Flavanols | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Cocoa Flavanols; Assigned to Arm(s): Flavanol | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Nestlé Noir intense 40 grx2 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nestlé Placebo Chocolate 40 grx2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Nestlé Noir intense 40 grx2; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Nestlé Placebo Chocolate 40 grx2; Assigned to Arm(s): 2
C: Arm Label: flavanol rich intervention; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Flavanol (410 mg) | Arm Label: flavanol free intervention; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Control (no flavanols) | Intervention Type: DIETARY_SUPPLEMENT; Name: Flavanol (410 mg); Assigned to Arm(s): flavanol rich intervention | Intervention Type: DIETARY_SUPPLEMENT; Name: Control (no flavanols); Assigned to Arm(s): flavanol free intervention
D: Arm Label: Dark chocolate; Type: EXPERIMENTAL; Interventions: Other: Flavanol-rich dark chocolate | Arm Label: Placebo chocolate; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo Chocolate | Intervention Type: OTHER; Name: Flavanol-rich dark chocolate; Assigned to Arm(s): Dark chocolate | Intervention Type: OTHER; Name: Placebo Chocolate; Assigned to Arm(s): Placebo chocolate

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Core Stabilization Enhance Neuromuscular Control and Functional Status of the Upper Extremity?
Brief Summary: The purpose of the study is to determine the effects of the addition of core stabilization exercises to a traditional upper extremity rehabilitation program in upper extremity injuries.


Options:
A: Arm Label: Typically Developing Infants; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home Program; Type: ACTIVE_COMPARATOR; Interventions: Other: Physical therapy | Arm Label: Perceptual-motor intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Physical therapy | Intervention Type: OTHER; Name: Physical therapy; Assigned to Arm(s): Home Program, Perceptual-motor intervention
B: Arm Label: Virtual reality video game; Type: ACTIVE_COMPARATOR; Interventions: Other: virtual reality system | Arm Label: Virtual reality system; Type: PLACEBO_COMPARATOR; Interventions: Other: virtual reality system | Intervention Type: OTHER; Name: virtual reality system; Assigned to Arm(s): Virtual reality system, Virtual reality video game
C: Arm Label: Stabilization Group; Type: EXPERIMENTAL; Interventions: Other: Core Stabilization, Other: Traditional upper extremity rehabilitation | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional upper extremity rehabilitation | Intervention Type: OTHER; Name: Core Stabilization; Assigned to Arm(s): Stabilization Group | Intervention Type: OTHER; Name: Traditional upper extremity rehabilitation; Assigned to Arm(s): Control Group, Stabilization Group
D: Arm Label: Intervention Stationary Cycling; Type: EXPERIMENTAL; Interventions: Other: Stationary Cycling | Intervention Type: OTHER; Name: Stationary Cycling; Assigned to Arm(s): Intervention Stationary Cycling

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Low Energy Density Diet and Weight Loss Maintenance
Brief Summary: Investigators presumed that low energy density (LED) diet consumers will have lower risk of cardiovascular disease and are able to maintain their weight longer .


Options:
A: Arm Label: Low energy dense; Type: EXPERIMENTAL; Interventions: Other: low energy dense, Other: diet | Arm Label: control; Type: EXPERIMENTAL; Interventions: Other: control, Other: diet | Intervention Type: OTHER; Name: low energy dense; Assigned to Arm(s): Low energy dense | Intervention Type: OTHER; Name: control; Assigned to Arm(s): control | Intervention Type: OTHER; Name: diet; Assigned to Arm(s): Low energy dense, control
B: Arm Label: Alternate day fasting; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Alternate day fasting | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Alternate day fasting; Assigned to Arm(s): Alternate day fasting
C: Arm Label: Fasting Day First; Type: OTHER; Interventions: Behavioral: Fasting First | Arm Label: Fed Day First; Type: OTHER; Interventions: Behavioral: Fed First | Intervention Type: BEHAVIORAL; Name: Fasting First; Assigned to Arm(s): Fasting Day First | Intervention Type: BEHAVIORAL; Name: Fed First; Assigned to Arm(s): Fed Day First
D: Arm Label: Intermittent Calorie Restriction; Type: EXPERIMENTAL; Interventions: Other: Calorie Restriction | Arm Label: Continuous Calorie Restriction; Type: EXPERIMENTAL; Interventions: Other: Calorie Restriction | Arm Label: Healthy Nutrition; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Calorie Restriction; Assigned to Arm(s): Continuous Calorie Restriction, Intermittent Calorie Restriction

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis : Randomized and Prospective Study
Brief Summary: Erythromycin has a prokinetic effect through Motilin receptor. It evokes migrating motor complex with longer and stronger contraction.

In patients with upper gastrointestinal bleeding, It has been shown that erythromycin could clear the stomach of blood, so visual examination could be improved.

Frequent food stasis is encounted when we examine patients with subtotal gastrectomy. It is postulated that erythromycin reduce food stasis and help to improve endoscopy in these cases.


Options:
A: Arm Label: Azithromycin; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Antibiotics; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo mixture | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Antibiotics | Intervention Type: OTHER; Name: Placebo mixture; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: Erythromycin; Assigned to Arm(s): N/A
D: Arm Label: erythromycin; Type: EXPERIMENTAL; Interventions: Drug: Erythromycin | Arm Label: saline; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Erythromycin; Assigned to Arm(s): erythromycin

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multimedia Based Information to Parents in a Pediatric Acute Ward: A Randomized Controlled Trial
Brief Summary: The aim of this study is to determine whether multimedia based health information presented in a pediatric acute ward to parents of children with breathing difficulties due to lower respiratory tract infections, is more effective than verbal information to reduce the parent's anxiety and to increase satisfaction with nursing care and health information.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: education | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: education; Assigned to Arm(s): A
B: Arm Label: Current Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Care Transition Intervention; Type: EXPERIMENTAL; Interventions: Other: Structured Telephone / Remote Outpatient Monitoring | Intervention Type: OTHER; Name: Structured Telephone / Remote Outpatient Monitoring; Assigned to Arm(s): Care Transition Intervention
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Care Transitions Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Care Transitions Intervention | Intervention Type: BEHAVIORAL; Name: Care Transitions Intervention; Assigned to Arm(s): Care Transitions Intervention
D: Arm Label: multimedia information; Type: EXPERIMENTAL; Interventions: Behavioral: Multimedia information | Arm Label: verbal information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: verbal information | Intervention Type: BEHAVIORAL; Name: Multimedia information; Assigned to Arm(s): multimedia information | Intervention Type: BEHAVIORAL; Name: verbal information; Assigned to Arm(s): verbal information

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guided Arterial Puncture: a Prospective, Blinded, Randomised Controlled Trial.
Brief Summary: The main purpose of the study is to evaluate whether the routine use of ultrasound guided arterial puncture can increase the proportion of patients who only needs one puncture attempt in order to successfully extract enough blood to make an arterial blood gas analysis, when ultrasound guided arterial puncture is compared to conventional arterial puncture technique.


Options:
A: Arm Label: Palpation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Palpation | Arm Label: Ultrasound; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guidance | Intervention Type: PROCEDURE; Name: Ultrasound guidance; Assigned to Arm(s): Ultrasound | Intervention Type: PROCEDURE; Name: Palpation; Assigned to Arm(s): Palpation
B: Arm Label: Ultrasound guided arterial puncture; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided arterial puncture | Arm Label: Conventional arterial puncture technique; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional arterial puncture technique | Intervention Type: PROCEDURE; Name: Ultrasound guided arterial puncture; Assigned to Arm(s): Ultrasound guided arterial puncture | Intervention Type: PROCEDURE; Name: Conventional arterial puncture technique; Assigned to Arm(s): Conventional arterial puncture technique
C: Arm Label: CAIG; Type: EXPERIMENTAL; Interventions: Device: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.; Assigned to Arm(s): CAIG
D: Arm Label: Ultrasound radial artery catheter; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided radial artery catheterization. | Arm Label: Palpation based artery catheterization; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blind insertion of radial artery catheterization | Intervention Type: PROCEDURE; Name: Ultrasound guided radial artery catheterization.; Assigned to Arm(s): Ultrasound radial artery catheter | Intervention Type: PROCEDURE; Name: Blind insertion of radial artery catheterization; Assigned to Arm(s): Palpation based artery catheterization

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guided Arterial Puncture: a Prospective, Blinded, Randomised Controlled Trial.
Brief Summary: The main purpose of the study is to evaluate whether the routine use of ultrasound guided arterial puncture can increase the proportion of patients who only needs one puncture attempt in order to successfully extract enough blood to make an arterial blood gas analysis, when ultrasound guided arterial puncture is compared to conventional arterial puncture technique.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Ultrasound; Type: EXPERIMENTAL; Interventions: Device: Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine) | Intervention Type: DEVICE; Name: Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine); Assigned to Arm(s): Ultrasound
B: Arm Label: Ultrasound guided arterial puncture; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided arterial puncture | Arm Label: Conventional arterial puncture technique; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional arterial puncture technique | Intervention Type: PROCEDURE; Name: Ultrasound guided arterial puncture; Assigned to Arm(s): Ultrasound guided arterial puncture | Intervention Type: PROCEDURE; Name: Conventional arterial puncture technique; Assigned to Arm(s): Conventional arterial puncture technique
C: Arm Label: Ultrasound group; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound -guided cannulation | Arm Label: Palpation group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Palpation -guided cannulation | Intervention Type: PROCEDURE; Name: Ultrasound -guided cannulation; Assigned to Arm(s): Ultrasound group | Intervention Type: PROCEDURE; Name: Palpation -guided cannulation; Assigned to Arm(s): Palpation group
D: Arm Label: Infant; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Arm Label: Preschool child; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Intervention Type: OTHER; Name: Long-axis/in-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child | Intervention Type: OTHER; Name: Short-axis/out-of-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child

Answer: B